Turbine is a pioneering technology company that is effectively virtualizing the laboratory. By leveraging high-fidelity biological simulations and artificial intelligence, Turbine enables researchers to predict the complex effects of potential drugs on cancer cells before a single physical experiment is performed. This approach significantly reduces the time and cost associated with drug discovery, offering a smarter pathway to identifying life-saving therapies.
Operating as a fast-paced, mission-driven organization, Turbine attracts world-class talent across computer science, biology, and data analysis. As a venture-backed scale-up, the company provides a dynamic environment where interdisciplinary teams collaborate across borders to solve some of the most difficult challenges in modern medicine.